glp-1 contraindications glp 1 receptor agonists Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Receptor Agonists: A Multidisciplinary Expert Consensus Who Should Avoid GLP-1 Weight
Description
Replenza wins on convenience and simplicity

Immune modulation effect of GLP-1 agonist

The dose can be increased to a 1.8 mg/dose for additional glycemic control (Table 1)

Self-pay options are also available
